Status:
COMPLETED
CPT-L to Improve Outcomes for Individuals With HIV and PTSD
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
PTSD
Hiv
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study plans to adapt and examine the acceptability and feasibility of an evidence-based PTSD treatment that has reduced other HIV transmission behavior (e.g., sexual risk), Cognitive Processing T...
Detailed Description
The prevalence of trauma exposure, and post-traumatic stress disorder (PTSD) in particular, among individuals living with HIV (30-74%) is higher than the general population (7-10%). Individuals with c...
Eligibility Criteria
Inclusion
- Individuals that are 18 years and older
- Linked with and/or eligible for treatment at a Ryan White clinic in South Carolina.
- Participant meets clinically significant threshold of DSM-V PTSD criteria as determined by a Clinician Administered PTSD Scale for DSM-5 (CAPS-5) clinical interview.
- No changes in psychotropic medication within 4 weeks of study enrollment.
- Able to speak, read, and write English.
- Meet at least one of the following HIV care criteria:
- Diagnosed with HIV in the last 3 months;
- Detectable viral load in the last 12 months;
- Failed to show up for or missed 1 or more HIV care appointments in the past 12 months;
- Last HIV care visit was more than 6 months ago;
- Self-reporting less than 90% ART adherence in the past 4 weeks.
- A score of at least 10 on the Montreal Cognitive Assessment test (MoCA)
Exclusion
- Evidence of significant cognitive impairment as assessed by the Montreal Cognitive Assessment Test (MoCA; in the severe range).
- Evidence of developmental delays, or pervasive developmental disorder, or active suicidal or homicidal ideations.
- Evidence of psychotic symptoms (e.g., active hallucinations, delusions, impaired thought processes).
Key Trial Info
Start Date :
July 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05275842
Start Date
July 13 2022
End Date
August 30 2024
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425